# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Morgan Stanley analyst Craig Hettenbach initiates coverage on HCA Healthcare (NYSE:HCA) with a Equal-Weight rating and annou...
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $378 ...
Cantor Fitzgerald analyst Sarah James reiterates HCA Healthcare (NYSE:HCA) with a Overweight and maintains $392 price target.
Cantor Fitzgerald analyst Sarah James reiterates HCA Healthcare (NYSE:HCA) with a Overweight and maintains $392 price target.
Truist Securities analyst David Macdonald maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $3...
UBS analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $405 to $438.